Literature for ALS 1-0635 (M10.013 inhibitor)

(Topics flags: I Inhibitor. To select only the references relevant to a single topic, click the link above. See explanation.)

2009
1. Baragi,V.M., Becher,G., Bendele,A.M., Biesinger,R., Bluhm,H., Boer,J., Deng,H., Dodd,R., Essers,M., Feuerstein,T., Gallagher,B.M., Jr., Gege,C., Hochgurtel,M., Hofmann,M., Jaworski,A., Jin,L., Kiely,A., Korniski,B., Kroth,H., Nix,D., Nolte,B., Piecha,D., Powers,T.S., Richter,F., Schneider,M., Steeneck,C., Sucholeiki,I., Taveras,A., Timmermann,A., Van Veldhuizen,J., Weik,J., Wu,X. and Xia,B.
   A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models
   Arthritis Rheum60, 2008-2018. PubMed  Europe PubMed DOI  I